Posted 13 March 2020 - 09:22 AM
Posted 13 March 2020 - 10:15 AM
Good find Hat - top two are same publication, and conclusion states;
"Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro... [we] suggest that they should be assessed in human patients suffering from the novel coronavirus disease."
But as the newsweek link states, the virus spreads quicker than the vaccine... isn't that always the way. Also, nice typo of "FAD-approved meds" mid-point in the article!!
However, given the history, it should have been given a priority as the article also states;
"After three coronavirus outbreaks in 20 years—severe acute respiratory syndrome, Middle East respiratory syndrome and now SARS-CoV-2—it's an investment that needs to be made."
Posted 13 March 2020 - 10:17 AM
Follow-up to that above...
"[according] to the director of the U.S. Centers for Disease Control and Prevention (CDC), Robert Redfield, remdesivir is already being given to COVID-19 patients. The U.S. Food and Drug Administration allows patients in the U.S. to use unapproved drugs in "life-threatening" situations when there are no other options, which explains why COVID-19 patients are permitted to take remdesivir."
Posted 13 March 2020 - 10:18 AM
IUN - Those life threatening situations are the ones I mentioned in the "Compassionate Care" scenario. That kind of use has been allowed, by regulation, for many decades especially in advanced cancer patients.
Posted 13 March 2020 - 10:37 AM
Sorry for the misleading information.
- invalidusername likes this
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users